Drugs / caricotamide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00746590 | Sep 2008 → Jun 2009 | hepatocellular carcinoma | BTG International Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | caricotamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00746590 ↗ |
| Known as | Caricotamida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2000716 ↗ |
| Modality | Small molecule | — CHEMBL2000716 ↗ |
| Route | Intravenous | “administered intravenously” NCT00746590 ↗ |